• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Puretech Health PLC (PRTC)

ORD 1P
Sell: 113.00p|Buy: 113.40p|Change: 1.40 (-1.22%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Company profile

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, whichderives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Address

6 St Andrew Street
5th Floor
London
GBR
EC4A 3AE

Website

https://www.puretechhealth.com

Sector 

Healthcare

Forecast key dates

NameKey Date
PureTech Health PLC Second Quarter Earnings Conference Call for 20272027-09-22T08:00:00
PureTech Health PLC Second Quarter Earnings Results for 20272027-09-22T00:00:00
PureTech Health PLC Annual General Meeting for 20272027-06-10T11:00:00
PureTech Health PLC Fourth Quarter Earnings Conference Call for 20262027-04-29T09:00:00
PureTech Health PLC Fourth Quarter Earnings Results for 20262027-04-29T00:00:00
PureTech Health PLC Annual Report for 20262027-04-29T00:00:00

Previous key dates

NameKey Date
PureTech Health PLC Second Quarter Earnings Conference Call for 20262026-09-22T08:00:00
PureTech Health PLC Second Quarter Earnings Result for 20262026-09-22T00:00:00
PureTech Health PLC Annual General Meeting for 20262026-06-10T11:00:00
PureTech Health PLC Fourth Quarter Earnings Conference Call for 20252026-04-29T09:00:00
PureTech Health PLC Fourth Quarter Earnings Result for 20252026-04-29T00:00:00
PureTech Health PLC Annual Report for 20252026-04-29T00:00:00
Leerink Partners Global Healthcare Conference2026-03-11T11:20:00
44th Annual J.P. Morgan Healthcare Conference2026-01-14T19:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.